Genomic Health Inc (GHDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,089 | -27,292 | -28,920 | -31,361 | -24,995 |
| Depreciation Amortization | 5,012 | 3,995 | 2,629 | 1,522 | 1,008 |
| Accounts receivable | -3,718 | -3,227 | -1,548 | -314 | N/A |
| Accounts payable and accrued liabilities | -68 | -557 | 1,130 | 292 | 274 |
| Other Working Capital | 1,033 | -1,759 | 2,574 | 1,101 | 611 |
| Other Operating Activity | 13,012 | 10,134 | 3,402 | 1,159 | -10 |
| Operating Cash Flow | $-818 | $-18,706 | $-20,733 | $-27,601 | $-23,112 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,110 | 137 | 21,465 | -50,688 | N/A |
| PPE Investments | -10,057 | -4,881 | -8,424 | -2,972 | -1,856 |
| Sale Of Investment | N/A | N/A | N/A | -58 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -500 | 50 |
| Investing Cash Flow | $-26,167 | $-4,744 | $13,041 | $-54,218 | $-1,806 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 4,912 | 4,090 | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -161 |
| Common Stock Issued | 1,679 | 50,235 | 179 | 58,710 | 144 |
| Other Financing Activity | -2,687 | -2,547 | -1,312 | -417 | 52,148 |
| Financing Cash Flow | $-1,008 | $47,688 | $3,779 | $62,383 | $52,131 |
| Beginning Cash Position | 39,164 | 14,926 | 18,839 | 38,275 | 11,062 |
| End Cash Position | 11,171 | 39,164 | 14,926 | 18,839 | 38,275 |
| Net Cash Flow | $-27,993 | $24,238 | $-3,913 | $-19,436 | $27,213 |
| Free Cash Flow | |||||
| Operating Cash Flow | -818 | -18,706 | -20,733 | -27,601 | -23,112 |
| Capital Expenditure | -10,057 | -4,881 | -8,424 | -2,972 | -1,856 |
| Free Cash Flow | -10,875 | -23,587 | -29,157 | -30,573 | -24,968 |